NEW
YORK, June 27, 2023 /PRNewswire/ -- Jakubowitz
Law announces that an investigation into potential securities
fraud allegations has
commenced on behalf of shareholders of Mersana Therapeutics, Inc.
(NASDAQ: MRSN).
To be contacted by a member of our team, fill out the
form:
https://claimyourloss.com/securities/mersana-class-action-loss-submission-form/?wire=4
Further details on the investigation: On June 15, 2023, Mersana issued a press release
"announc[ing] that the U.S. Food and Drug Administration (FDA) has
issued a partial clinical hold pausing new patient enrollment in
UP-NEXT and UPGRADE-A, the company's ongoing clinical trials of
UpRi in platinum-sensitive ovarian cancer. UPLIFT, Mersana's
ongoing clinical trial of UpRi in platinum-resistant ovarian
cancer, completed enrollment in October
2022." Mersana stated that "[t]he partial clinical hold
follows a submission by Mersana of a recent aggregate safety report
of all patients dosed with UpRi (approximately 560 patients)
evaluating bleeding events" and that "Mersana's recent assessment
determined that serious bleeding events appear to occur at a higher
rate than background. While most bleeding cases in this aggregate
safety analysis were low-grade, five (<1%) Grade 5 (fatal)
bleeding events were observed among the approximately 560 patients
dosed to date. The causes of bleeding events remain under
investigation."
On this news, Mersana's stock price fell $5.66 per share, or 59.27%, to close at
$3.89 per share on June 15, 2023.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities
fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/mrsn-fraud-alert-jakubowitz-law-is-investigating-mersana-therapeutics-inc-in-connection-with-potential-violations-of-federal-securities-laws-301857605.html
SOURCE Jakubowitz Law